[CAS NO. 1803274-65-8]  BAY 1436032

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [1803274-65-8]

Distributor
Catalog
AS941201
Brand
Arctom Scientific
CAS
1803274-65-8

DESCRIPTION [1803274-65-8]

Overview

MDL-
Molecular Weight489.53
Molecular FormulaC26H30F3N3O3
SMILESO=C(O)CCC1=CC=C2N([C@H]3CC(C)(C)C[C@@H](C)C3)C(NC4=CC=C(OC(F)(F)F)C=C4)=NC2=C1

For research use only.

Storage

3 years,-20°C,powder
1 years,-80°C,in solvent

Shipping

Room temperature shipping(Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

1 mg5 mg10 mg
1 mM2.0428 mL10.2139 mL20.4278 mL
5 mM0.4086 mL2.0428 mL4.0856 mL
10 mM0.2043 mL1.0214 mL2.0428 mL
50 mM0.0409 mL0.2043 mL0.4086 mL

Description

BAY-1436032 is a highly selective, potent and orally available inhibitor of . It is a double-digit nanomolar and selective pan-inhibitor of the enzymatic activity of various IDH1-R132X mutants in vitro and displays potent inhibition of 2-HG release (nanomolar range) in patient derived and engineered cell lines expressing different IDH1 mutants.

Targets

IDH1 (R132H) [1]
(Cell-free assay)
IDH1 (R132C) [1]
(Cell-free assay)
15 nM15 nM

In vitro

BAY 1436032 exhibits an IC50 of 15 nM for mutant IDH1R132H protein and virtually no effect on wild-type IDH1 and the structurally related IDH2 proteins with IC50 of 20 and >100 µM, respectively. BAY 1436032 not only reduces 2-HG levels in cells with the IDH1R132H or the IDH1R132C mutations, but also in those with the R132G, R132S or R132L mutations with equal efficiency. There is no inhibition of IDH2 R172M. BAY 1436032 reduces proliferation and induces differentiation in primary glioma cultures. BAY 1436032 reveals low metabolic clearance (CL) in vitro in rat hepatocytes and mice liver microsomes.